HU192990B - Process for producing new compositions for injection containing 1-/2-hydroxy-ethyl/-2-methyl-5-nitro-imidazol - Google Patents

Process for producing new compositions for injection containing 1-/2-hydroxy-ethyl/-2-methyl-5-nitro-imidazol Download PDF

Info

Publication number
HU192990B
HU192990B HU843127A HU312784A HU192990B HU 192990 B HU192990 B HU 192990B HU 843127 A HU843127 A HU 843127A HU 312784 A HU312784 A HU 312784A HU 192990 B HU192990 B HU 192990B
Authority
HU
Hungary
Prior art keywords
particle size
methyl
metronidazole
maximum particle
hydroxyethyl
Prior art date
Application number
HU843127A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT35650A (en
Inventor
John H Bell
Robert P Haslam
Andrew Lewis
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of HUT35650A publication Critical patent/HUT35650A/hu
Publication of HU192990B publication Critical patent/HU192990B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU843127A 1983-08-19 1984-08-17 Process for producing new compositions for injection containing 1-/2-hydroxy-ethyl/-2-methyl-5-nitro-imidazol HU192990B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (2)

Publication Number Publication Date
HUT35650A HUT35650A (en) 1985-07-29
HU192990B true HU192990B (en) 1987-08-28

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
HU843127A HU192990B (en) 1983-08-19 1984-08-17 Process for producing new compositions for injection containing 1-/2-hydroxy-ethyl/-2-methyl-5-nitro-imidazol

Country Status (17)

Country Link
JP (1) JPS6067468A (sv)
AU (1) AU577055B2 (sv)
BE (1) BE900381A (sv)
CA (1) CA1214727A (sv)
CH (1) CH662812A5 (sv)
DE (1) DE3430354A1 (sv)
DK (1) DK165817C (sv)
FR (1) FR2560043B1 (sv)
GB (2) GB8322364D0 (sv)
HU (1) HU192990B (sv)
IL (1) IL72714A (sv)
IT (1) IT1213208B (sv)
LU (1) LU85511A1 (sv)
NL (1) NL8402510A (sv)
NZ (1) NZ209270A (sv)
SE (1) SE460095B (sv)
ZA (1) ZA846431B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (de) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoeherer freisetzung der wirkstoffe

Also Published As

Publication number Publication date
IT8422323A0 (it) 1984-08-13
SE8404130L (sv) 1985-02-20
ZA846431B (en) 1985-03-27
BE900381A (fr) 1985-02-18
NL8402510A (nl) 1985-03-18
JPS6067468A (ja) 1985-04-17
LU85511A1 (fr) 1985-04-24
FR2560043A1 (fr) 1985-08-30
DK397084D0 (da) 1984-08-17
DK165817B (da) 1993-01-25
FR2560043B1 (fr) 1988-08-05
IT1213208B (it) 1989-12-14
SE460095B (sv) 1989-09-11
GB8322364D0 (en) 1983-09-21
NZ209270A (en) 1988-02-29
IL72714A (en) 1988-09-30
DK165817C (da) 1993-06-21
GB8420959D0 (en) 1984-09-19
GB2145088A (en) 1985-03-20
SE8404130D0 (sv) 1984-08-17
DK397084A (da) 1985-02-20
AU577055B2 (en) 1988-09-15
CH662812A5 (fr) 1987-10-30
DE3430354A1 (de) 1985-03-07
AU3202284A (en) 1985-02-21
CA1214727A (en) 1986-12-02
GB2145088B (en) 1986-10-08
HUT35650A (en) 1985-07-29

Similar Documents

Publication Publication Date Title
US8614210B2 (en) Process for preparing pharmaceutical ophthalmic compositions
JP2002510652A (ja) 共溶媒処方物
ZA200206688B (en) Esmolol formulation.
DE60215129T2 (de) Esmolol-enthaltende zubereitungen
US4038389A (en) Medroxyprogesterone acetate compositions
HU192990B (en) Process for producing new compositions for injection containing 1-/2-hydroxy-ethyl/-2-methyl-5-nitro-imidazol
US20160279139A1 (en) An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions
JP6279395B2 (ja) ブリンゾラミド懸濁性点眼液組成物の製造方法
US4029782A (en) Cefazolin suspension for parenteral administration
AU2013290826B2 (en) Injectable antibiotic formulations and their methods of use
WO2020136466A1 (en) An injectable skeletal muscle relaxant and nsaid and method of making the same
IE902790A1 (en) Formulations of phenytoin sodium for intravenous¹administration
KR0169711B1 (ko) 수의학적 조성물
US9820991B2 (en) Pharmaceutical composition comprising brinzolamide
EP2874623B1 (en) Injectable antibiotic formulations and their methods of use
TWI631948B (zh) 可注射型抗生素配方及其使用方法
NZ613138B2 (en) Injectable antibiotic formulations and their methods of use
JP2002544164A (ja) ５−（２−クロロエチル）−４−メチルチアゾールエジシレート（クロメチアゾールエジシレート）の非経口処方物

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee